Generation of genetically modified mice using CRISPR/Cas9 system requires the delivery of CRISPR reagents into the genome. Some scientists use pronuclear microinjection of

CRISPR reagents while the others use cytoplasmic microinjection. What are the determinant factors for using each of them? in other words, what is the advantages and disadvantages of using each of them?

Thanks in advance!